Guided Therapeutics, Inc.
Early Detection, Better Outcomes.
Early Detection, Better Outcomes.
Guided Therapeutics, Inc. is a biotechnology startup founded in 1992 with the mission of enabling Early Detection, Better Outcomes. The company is committed to revolutionizing disease detection with its patented biophotonic technology. This innovative approach promises earlier, more accurate, and more efficient disease diagnosis compared to traditional tests. Based in the United States, Guided Therapeutics recently secured a significant $3.30M Post-IPO Debt investment on 07 September 2022. This investment signifies confidence in the company's potential to make a significant impact in the health care industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | $3.30M | - | 07 Sep 2022 | |
| Post-IPO Equity | $2.11M | - | 16 Feb 2021 | |
| Post-IPO Equity | $2.50M | - | 15 Jul 2015 | |
| Post-IPO Debt | $3.00M | - | 14 May 2014 | |
| Post-IPO Equity | $2.53M | - | 03 Jun 2013 |
No recent news or press coverage available for Guided Therapeutics, Inc..
We care about your data, and we'd love to use cookies make your experience better.
